Related Experiment Video
Updated: Mar 17, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy
Julian O M Ormerod1, Michael P Frenneaux2, Mark V Sherrid3
1Oxford Heart Centre, Oxford University Hospitals, Headley Way, Oxford, OX3 9DU, UK.
Insights
Hypertrophic cardiomyopathy (HCM) involves inefficient cardiomyocyte energy use. This leads to dynamic systolic dysfunction, a reversible condition that worsens with outflow obstruction, explaining unique clinical features in HCM patients.
Area of Science:
- Cardiology
- Molecular Cardiology
- Genetic Cardiology
Background:
- Hypertrophic cardiomyopathy (HCM) is linked to inefficient cardiomyocyte energy utilization and cellular energy depletion.
- Clinical presentation of HCM often includes normal or hyperkinetic left ventricular (LV) systolic function at rest, posing a paradox to energy depletion theories.
Purpose of the Study:
- To explore the 'lobster claw abnormality,' a reversible systolic dysfunction in obstructive HCM.
- To propose that this abnormality, termed 'dynamic systolic dysfunction,' is a manifestation of inefficient cardiomyocyte energy utilization.
Main Methods:
- This Perspectives article reviews existing evidence and proposes a new conceptual framework.
- Focuses on the 'lobster claw abnormality' and its implications in obstructive HCM.
Main Results:
- Dynamic systolic dysfunction explains mid-systolic aortic valve closure and bifid aortic pressure tracings in obstructive HCM.
- This dysfunction underlies apical aneurysms and cardiogenic shock in some obstructive HCM cases.
- The study posits that dynamic systolic dysfunction becomes apparent under increased afterload (obstruction) due to energy inefficiency.
Conclusions:
- Dynamic systolic dysfunction, driven by inefficient cardiomyocyte energy use, is a key feature of HCM, particularly under obstruction.
- This paradigm may offer insights into novel therapeutic strategies for HCM.
- Alternative mechanisms like myofilament Ca2+ hypersensitivity and enhanced late Na+ current in HCM are also considered.
Abstract:
Evidence indicates that anatomical and physiological phenotypes of hypertrophic cardiomyopathy (HCM) stem from genetically mediated, inefficient cardiomyocyte energy utilization, and subsequent cellular energy depletion. However, HCM often presents clinically with normal left ventricular (LV) systolic function or hyperkinesia. If energy inefficiency is a feature of HCM, why is it not manifest as resting LV systolic dysfunction? In this Perspectives article, we focus on an idiosyncratic form of reversible systolic dysfunction provoked by LV obstruction that we have previously termed the 'lobster claw abnormality' - a mid-systolic drop in LV Doppler ejection velocities. In obstructive HCM, this drop explains the mid-systolic closure of the aortic valve, the bifid aortic pressure trace, and why patients cannot increase stroke volume with exercise. This phenomenon is characteristic of a broader phenomenon in HCM that we have termed dynamic systolic dysfunction. It underlies the development of apical aneurysms, and rare occurrence of cardiogenic shock after obstruction. We posit that dynamic systolic dysfunction is a manifestation of inefficient cardiomyocyte energy utilization. Systolic dysfunction is clinically inapparent at rest; however, it becomes overt through the mechanism of afterload mismatch when LV outflow obstruction is imposed. Energetic insufficiency is also present in nonobstructive HCM. This paradigm might suggest novel therapies. Other pathways that might be central to HCM, such as myofilament Ca2+ hypersensitivity, and enhanced late Na+ current, are discussed.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

